These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9821849)

  • 41. The catecholamine-beta-adrenoreceptor-cAMP system and prediction of cardiovascular events in hypertension.
    Peng YX; Shan J; Qi XY; Zhang SJ; Ma SP; Wang N; Li JP; Xue H; Wu M
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):227-31. PubMed ID: 16487266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
    Ibsen H; Julius S
    Fed Proc; 1984 Jan; 43(1):67-71. PubMed ID: 6317465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
    Snapir A; Koskenvuo J; Toikka J; Orho-Melander M; Hinkka S; Saraste M; Hartiala J; Scheinin M
    Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potency, affinity constants and receptor reserves for noradrenaline and adrenaline on aortae from aged normo- and hypertensive rats.
    Doggrell SA; Chen YY
    J Pharm Pharmacol; 2001 Feb; 53(2):205-12. PubMed ID: 11273017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship between some beta-adrenergic mediated responses and plasma concentrations of adrenaline and cyclic AMP in man.
    Philipsen EK; Myhre J; Larsen S; Damkjaer Nielsen M; Holst JJ; Hilsted J
    Acta Endocrinol (Copenh); 1990 Jan; 122(1):115-20. PubMed ID: 1968306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal cardiovascular reactivity in borderline and mild essential hypertension.
    de Champlain J; Petrovich M; Gonzalez M; Lebeau R; Nadeau R
    Hypertension; 1991 Apr; 17(4 Suppl):III22-8. PubMed ID: 2013489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adrenaline and noradrenaline increase contractile force of human ventricle through both beta 1- and beta 2-adrenoceptors.
    Kaumann AJ
    Biomed Biochim Acta; 1987; 46(8-9):S411-6. PubMed ID: 2829863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Plasma adrenaline and noradrenaline in essential and renal hypertension (author's transl)].
    Skrabal F; Auböck J; Hörtnagl H; von Brücke T
    Wien Klin Wochenschr; 1981 May; 93(10):321-5. PubMed ID: 7020260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circadian variation in adrenergic responses in asthmatic subjects.
    Barnes PJ; Fitzgerald GA; Dollery CT
    Clin Sci (Lond); 1982 Apr; 62(4):349-54. PubMed ID: 6279351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension.
    Bertel O; Bühler FR; Kiowski W; Lütold BE
    Hypertension; 1980; 2(2):130-8. PubMed ID: 6247266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for presynaptic beta-adrenoceptor stimulation 24 hours after a 6 hour adrenaline infusion.
    Bachmann AW; Gordon RD; Ballantine DM
    Clin Exp Pharmacol Physiol; 1992 May; 19(5):311-4. PubMed ID: 1325881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
    Brodde OE; Daul A; O'Hara N; Bock KD
    J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha 1-and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of normotensive and hypertensive subjects.
    Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1986; 8(1):190-6. PubMed ID: 2419684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker.
    Struthers AD; Whitesmith R; Reid JL
    Br Heart J; 1983 Sep; 50(3):277-81. PubMed ID: 6615664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased plasma adrenaline concentrations in benign essential hypertension.
    Franco-Morselli R; Elghozi JL; Joly E; Di Giuilio S; Meyer P
    Br Med J; 1977 Nov; 2(6097):1251-4. PubMed ID: 589124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular and metabolic responses to low dose adrenaline infusion: an invasive study in humans.
    Freyschuss U; Hjemdahl P; Juhlin-Dannfelt A; Linde B
    Clin Sci (Lond); 1986 Feb; 70(2):199-206. PubMed ID: 3956110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension.
    Kjeldsen SE; Eide I; Aakesson I; Leren P
    Scand J Clin Lab Invest; 1983 Jun; 43(4):343-9. PubMed ID: 6635541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adrenaline activation of prejunctional beta-adrenoceptors and hypertension.
    Majewski H; Tung LH; Rand MJ
    J Cardiovasc Pharmacol; 1982; 4(1):99-106. PubMed ID: 6176807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.